F. Hoffmann-La Roche Ltd (Roche) has a rich history of antibody therapies to treat cancers (malignancies) that affect B cells (a type of white blood cell), including non-Hodgkin lymphoma and chronic lymphocytic leukaemia. While dependent on the type of cancer and the stage when the cancer is diagnosed, the outcomes for patients with B-cell malignancies are generally poor and require further improvement.
- Juana Hernandez
- Tina Nielsen
- Michael Wenger
